RT journal article T1 Inactivation of the PHD3-FOXO3 axis blunts the type I interferon response in microglia and ameliorates Alzheimer's disease progression A1 Sánchez García, Manuel A. A1 Lara Ureña, Nieves A1 March-Díaz, Rosana A1 Ortega-De San Luis, Clara A1 Quiñones-Cañete, Silvia A1 Mora-Romero, Bella A1 Barba Reyes, Juan Manuel A1 Cabello-Rivera, Daniel A1 Romero-Molina, Carmen A1 Heras-Garvin, Antonio A1 Navarro, Victoria A1 López Barneo, José A1 Vizuete, Marisa A1 Vitórica, Javier A1 Muñoz-Cabello, Ana M. A1 Muñoz Manchado, Ana Belén A1 Cokman, Matthew E. A1 Rosales-Nieves, Alicia E. A1 Pascual, Alberto A2 Neurociencias K1 Alzheimer Disease K1 Amyloid beta-Peptides K1 Animals K1 Disease Models K1 Animal K1 Disease Progression K1 Forkhead Box Protein O3 K1 Humans K1 Hypoxia-Inducible Factor-Proline Dioxygenases K1 Interferon Type I K1 Mice K1 Microglia K1 Signal Transduction K1 Neurodegenerative diseases K1 amyloid beta protein K1 FoxO3 protein, mouse K1 interferon K1 transcription factor FKHRL1 K1 Alzheimer K1 In-vitro K1 In-vivo K1 Interferon response K1 Microglia K1 Phagocytose K1 Signature genes K1 Transcriptional response K1 disease exacerbation K1 disease model K1 genetics K1 human K1 metabolism K1 microglia K1 mouse K1 pathology K1 signal transduction K1 Transcription AB Microglia respond to Alzheimer’s disease (AD) with varied transcriptional responses. We show that oligomeric Aß (oAß) induces the expression of Hif1a and Egln3 in microglia in vitro, together with the transcription of the type I interferon signature (IFNS) genes in a PHD3-dependent manner. We identify FOXO3 as a repressor of IFNS, whose abundance decreases upon PHD3 induction in response to oAß. In vivo, loss of PHD3 correlates with abrogation of the IFNS and activation of the disease-associated microglia signature, an increase in microglia proximity to Aß plaques and phagocytosis of both Aß and small plaques. PHD3 deficiency mitigated the Aß plaque–associated neuropathology and rescued behavioral deficits of an AD mouse model. Last, we demonstrate that microglial PHD3 overexpression in the absence of Aß pathology is sufficient to induce the IFNS and behavioral alterations. Together, our data strongly indicate that the inactivation of the PHD3-FOXO3 axis controls the microglial IFNS in a cell autonomous manner, improving AD outcome. PB American Association for the Advancement of Science SN 2375-2548 YR 2025 FD 2025 LK http://hdl.handle.net/10498/38158 UL http://hdl.handle.net/10498/38158 LA eng DS Repositorio Institucional de la Universidad de Cádiz RD 18-nov-2026